ROSSO-in-praxi-international: Long-Term Effects of Self-Monitoring of Blood Glucose on Glucometabolic Control in Patients with Type 2 Diabetes Mellitus Not Treated with Insulin

2013 ◽  
Vol 15 (1) ◽  
pp. 89-96 ◽  
Author(s):  
Kerstin Kempf ◽  
Tsvetalina Tankova ◽  
Stephan Martin
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Long Term Effects ◽  
Self Monitoring

scholarly journals Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis

2016 ◽  
Vol 89 (6) ◽  
pp. 1380-1387 ◽  
Author(s):  
Vera Krane ◽  
Kay-Renke Schmidt ◽  
Lena J. Gutjahr-Lengsfeld ◽  
Johannes F.E. Mann ◽  
Winfried März ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Long Term Effects

scholarly journals Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin

2012 ◽  
Author(s):  
Uriëll L Malanda ◽  
Laura MC Welschen ◽  
Ingrid I Riphagen ◽  
Jacqueline M Dekker ◽  
Giel Nijpels ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Self Monitoring

scholarly journals Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus

2009 ◽  
Vol 169 (6) ◽  
pp. 616 ◽  
Author(s):  
Adriaan Kooy ◽  
Jolien de Jager ◽  
Philippe Lehert ◽  
Daniël Bets ◽  
Michiel G. Wulffelé ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Macrovascular Disease ◽  
Long Term Effects

scholarly journals Hypoglycaemia among adults with Type 2 Diabetes mellitus in a Family Medicine Clinic

2021 ◽  
Vol 7 (4) ◽  
pp. 336-346
Author(s):  
OO Sodipo ◽  
AB Ademolu ◽  
S Odunaye-Badmus ◽  
EO Oluwatuyi ◽  
R Odiana
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Family Medicine ◽  
Self Monitoring ◽  
Medicine Clinic ◽  
Clinical Records ◽  
Dipeptidylpeptidase 4

Background: The prevalence of Diabetes mellitus (DM) is increasing worldwide. The complications of DM arising from hyperglycaemia are well documented and. However, there is a lack of data, poor awareness and information on hypoglycaemia in DM. Objective: To describe the prevalence and factors associated with hypoglycaemia among patients with Type 2 Diabetes mellitus (DM). Methods: This was a retrospective study of the clinical records of patients with Type 2 DM at the Family Medicine Clinic of a Nigerian teaching hospital from January 2019 to January 2020. The sociodemographic and clinical characteristics, including hypoglycaemia, Glycosylated Haemoglobin (HbA1c), Fasting and Random blood glucose, were retrieved. Results: A total number of 570 patients were assessed, with a prevalence of 43 (7.5%) of hypoglycaemia. The mean age of the patients in the study was 58.2±10.9 years (range: 36-83 years). Metformin (557; 97.7%), Sulphonylureas (377; 66.1%), Dipeptidylpeptidase -4 inhibitors (137; 24.0%) and insulin (72; 12.6%) were the most prescribed anti-diabetic medications. hypoglycaemiaA majority (29; 67.4%) of the hypoglycaemia episodes occurred in the morning, while most (24; 55.8%) of the episodes of hypoglycaemia were mild. Mean age (t= 2.35; p = 0.019), presence of hypertension (X2 = 6.92, p = 0.008) and dyslipidaemia (X2 = 7.86, p = 0.005) were associated with hypoglycaemia. Conclusions: The prevalence of hypoglycaemia in the Outpatient clinic was low, while the presence of comorbidities                                   (hypertension and dyslipidaemia) and age were associated with hypoglycaemia. There is a need for patient education and Self-Monitoring of Blood Glucose (SMBG) to prevent complications of hypoglycaemia. hypoglycaemia

Sign in / Sign up

Export Citation Format

Share Document